The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Novartis; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Takeda
Research Funding - Novartis; Takeda
Considerations for tisagenlecleucel dosing rationale.
 
Rakesh Awasthi
Employment - Novartis Institutes for BioMedical Research
Stock and Other Ownership Interests - Aeterna Zentaris; Cara Therapeutics; Exelixis; Ultragenyx Pharmaceuticals
 
Karen Thudium Mueller
Employment - Novartis Institutes for BioMedical Research
Stock and Other Ownership Interests - Novartis Institutes for BioMedical Research
Patents, Royalties, Other Intellectual Property - Patent pending
 
Gregory A. Yanik
No Relationships to Disclose
 
Constantine Si Lun Tam
Honoraria - Abbvie; Janssen; Novartis
Research Funding - Abbvie (Inst); Janssen (Inst)
 
Susana Rives
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis; Shire
Research Funding - Shire
Travel, Accommodations, Expenses - Jazz Pharmaceuticals; Novartis; Shire
 
Joseph McGuirk
Honoraria - Kite, a Gilead company; Novartis
Research Funding - Astellas Pharma (Inst); Bellicum Pharmaceuticals (Inst); Fresenius Biotech (Inst); Gamida Cell (Inst); Novartis (Inst); Novartis (Inst); Pluristem Therapeutics (Inst)
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Michael W. Boyer
Honoraria - Novartis
 
Ulrich Jäger
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Research Funding - Gilead Sciences (Inst); Novartis (Inst); Roche (Inst)
 
Andre Baruchel
Honoraria - Jazz Pharmaceuticals
Consulting or Advisory Role - Amgen; Celgene; Jazz Pharmaceuticals; Roche; SERVIER
Research Funding - Shire (Inst)
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Gary Douglas Myers
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
Research Funding - Novartis (Inst)
 
Peter Borchmann
No Relationships to Disclose
 
Samantha Mary Jaglowski
Consulting or Advisory Role - Juno Therapeutics; Kite, a Gilead company; Novartis
Research Funding - Kite, a Gilead company; Novartis
 
Heather E Stefanski
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis
 
Michael Russell Bishop
Employment - UnitedHealthcare
Honoraria - Celgene
Consulting or Advisory Role - Seagen
Speakers' Bureau - Celgene; Juno Therapeutics; Novartis
 
Edward K Waldron
Employment - Novartis
 
Jason Hamilton
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Mariana Cota
Employment - Novartis
 
Lida Bubuteishvili-Pacaud
Employment - Novartis
 
Edmund K. Waller
Employment - Cambium Medical Technologies
Leadership - Cambium Medical Technologies
Stock and Other Ownership Interests - Cambium Medical Technologies; Cerus; Chimerix
Consulting or Advisory Role - Amgen; Celldex; Kalytera Therapeutics; Novartis
Research Funding - Celldex; Novartis
Patents, Royalties, Other Intellectual Property - Cambium Medical Technologies
Travel, Accommodations, Expenses - Amgen; Novartis